Christopher R. Fenimore, SVP Controller at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,844 shares at $749.00 ($1.4M) on 2022-10-05, disclosed to the SEC on 2022-10-07.
Open-market sale of $1.4M REGN by SVP Controller. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| REGN | SELL | 2023-12-29 | $4.2M | — | Filing → |
| REGN | SELL | 2023-12-26 | $3.3M | — | Filing → |
| REGN | SELL | 2023-03-27 | $3.5M | — | Filing → |